Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report

Free Research Reports on CHTP, ECYT, MFRM and RVLT Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1001652&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 03/28/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shares spiked 8.40 percent on more than 6 million shares traded Wednesday to close at $2.00 a share. The company plans to resubmit a New Drug Application for Northera in late second quarter 2013.

Find out more about Chelsea Therapeutics including full access to the free equity report at: www.BedfordReport.com/CHTP

Endocyte, Inc. (NASDAQ: ECYT) shares gained 11.16 percent on volume of nearly 1.0 million shares traded Wednesday to close at $11.95 a share. Endocyte has a pipeline of folate receptor-targeted SMDCs in various stages of clinical and preclinical development for the treatment of folate receptor-positive cancers and inflammatory diseases.

Find out more about Endocyte including full access to the free equity report at: www.BedfordReport.com/ECYT

Mattress Firm Holding Corp (NASDAQ: MFRM) shares surged 12.09 percent on over five times the average daily volume Wednesday to close at $34.77 a share. The company reported net sales of $1,007.3 million for the full fiscal year, an increase of 43.1 percent when compared to a year ago.

Find out more about Mattress Firm including full access to the free equity report at: www.BedfordReport.com/MFRM

Revolution Lighting Technologies Inc. (NASDAQ: RVLT) shares soared 26.95 percent on volume of nearly 5.0 million shares traded Wednesday to close at $2.12 a share. LED manufacturers have surged in 2013 on the prospects of growth within the lighting market. Greg Sebasky, CEO of Philips' North American Unit, expects the LED lighting market to grow by 40 percent in 2013.

Find out more about Revolution Lighting Technologies including full access to the free equity report at: www.BedfordReport.com/RVLT

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today